Combining standard clinical blood values for improving survival prediction in patients with unresectable esophageal carcinoma: A retrospective study.

Medicine (Baltimore) · 2025 · PMC12440474 · PMID 40958277

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Analysis of OS showed a clear trend of decreasing median OS with increasing LabBM scores: 27.9 months for the low LabBM group, 13.1 months for the medium LabBM group, and 9.3 months for the high LabBM group.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.